1-3 of 3
Esther M.M. Ooi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Open Access
Dick C. Chan, PHD, Gerald F. Watts, MD, DSC, Seng Khee Gan, MD, PHD, Esther M.M. Ooi, PHD, P. Hugh R. Barrett, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(5):1134–1139
https://doi.org/10.2337/dc09-1765
Published: 15 February 2010
View articletitled, Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Open the PDF for Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet in another window
Includes: Supplementary data
Journal Articles

Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome

Open Access
Dick C. Chan, PHD, Gerald F. Watts, MD, DSC, Esther M.M. Ooi, PHD, Kerry-Anne Rye, PHD, Juying Ji, PHD, Anthony G. Johnson, MD, P. Hugh R. Barrett, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(11):2111–2113
https://doi.org/10.2337/dc09-0519
Published: 03 August 2009
View articletitled, Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome
Open the PDF for Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome in another window
Journal Articles

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome

Free
Esther M.M. Ooi, PHD, Gerald F. Watts, MD, DSC, Dick C. Chan, PHD, Meifania M. Chen, BSC, Paul J. Nestel, MD, Dmitri Sviridov, MD, PHD, P. Hugh R. Barrett, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(8):1656–1661
https://doi.org/10.2337/dc08-0358
Published: 01 August 2008
View articletitled, Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
Open the PDF for Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome in another window